80631-107 : Novavax Covid-19 Vaccine, Adjuvanted 5 ug/.5ml Intramuscular Injection, Suspension
| NDC: | 80631-107 |
| Labeler: | Novavax, Inc. |
| Product Type: | Vaccine |
| Drug Name: | Novavax Covid-19 Vaccine, Adjuvanted |
| Dosage Form: | Intramuscular Injection, Suspension |
| Rev. Date: |
NDC Package Codes:
- 80631-107-10: 10 SYRINGE, GLASS IN 1 CARTON (80631‑107‑10) / .5 ML IN 1 SYRINGE, GLASS (80631‑107‑01)
Active Ingredients:
- Nvx-cov2705
Dosage Strength:
- 5 ug/.5mL
Related Products:
Based on records with the same trade name.- 80631-100 Novavax Covid-19 Vaccine, Adjuvanted 5 ug/.5ml Intramuscular Injection, Suspension by Novavax, Inc.
- 80631-102 Novavax Covid-19 Vaccine, Adjuvanted 5 ug/.5ml Intramuscular Injection, Suspension by Novavax, Inc.
- 80631-105 Novavax Covid-19 Vaccine, Adjuvanted 5 ug/.5ml Intramuscular Injection, Suspension by Novavax, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 80631-105Next: 80631-200 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
